beigene

This global oncology company, headquartered in Cambridge, Massachusetts, U.S., Beijing, China, and Basel, Switzerland, specializes in the development of drugs for cancer treatment. Founded in 2010 by Xiaodong Wang, it is led by CEO John V. Oyler. As of 2024, it employs 10,600 people and generated a revenue of 2.459 billion USD in 2023.